Cyclin D1 overexpression and prognosis in colorectal adenocarcinoma

Oncology

Volumn 55, Issue 2, 1998, Pages 145-151

  Maeda, Kiyoshi ^a   Chung, Yong Suk ^a   Kang, Soon Myoung ^a   Ogawa, Masafumi ^a   Onoda, Naoyoshi ^a   Nishiguch, Yukio ^a   Ikehara, Teruyuki ^a   Nakata, Bunzo ^a   Okuno, Masahiro ^b   Sowa, Michio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaka City Gen Med Treatm Center   (Japan)

Author keywords

Colorectal adenocarcinoma; Cyclin D1; Disease recurrence; Prognosis

Indexed keywords

CYCLIN D1; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; ADENOCARCINOMA; CHEMISTRY; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; MALE; MIDDLE AGED; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SURVIVAL; UPREGULATION;

ADENOCARCINOMA; ADULT; AGED; COLORECTAL NEOPLASMS; CYCLIN D1; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS; UP-REGULATION;

EID: 0031594749     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000011849     Document Type: Article

References (27)

1. Eisenberg B, DeCosse JJ, Harford F, Michalek J: Carcinoma of the colon and rectum: The natural history reviewed in 1,704 patients. Cancer 1982;49:1131-1134.
2. Fortner JG, Silva JS, Golbey RB, Cox EB, Maclean BJ: Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. Ann Surg 1982;199:306-316.
3. Kelly CJ, Daly JM: Colorectal cancer - Principles of postoperative follow-up. Cancer 1992; 70:1397-1408.
4. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A: A novel cyclin encoded by a bei 1-linked candidate oncogene. Nature 1991;350:512-515.
5. 1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 1994;74:152-158.
6. 1 mRNA and antigen in esophageal cancer. Am J Pathol 1995;146:1161-1169.
7. 1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995;55:975-978.
8. 1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 1996;73:728-734.
9. Morson BC, Sobin LH: Histological Typing of Intestinal Tumors. Tech Rep No 15. Geneva, World Health Organization, 1976.
10. Harmanek P, Sobin LH (ed): TNM Classification of Malignant Tumors: Colon and Rectum, ed 4. Berlin, Springer, 1987, pp 47-49.
11. 1 overexpression in colorectal cancer (in Japanese). J Clin Exp Med (Igaku no ayumi), 1996;177:719-720.
12. Cox DR: Regression models and life tables. J R Stat Soc B 1973;31:1333-1335.
13. Zeng ZS, Sarkis AS, Zhang ZF, Klimstra DS, Charytonowitcz E, Guillem JG, Cordon-Cardo C, Cohen AM: p53 overexpression: An independent predictor of survival in lymph node-positive colorectal cancer patients. J Clin Oncol 1994;12:2043-2050.
14. Auvinen A, Isola JJ, Visacorpi T, Koivula T, Virta S, Hamak M: Overexpression of p53 and long-term survival in colon carcinoma. Br J Cancer 1994;70:293-296.
15. Houbiers JGA, Van Der Burg SH, Van De Watering LMG, Tollenaar RAEM, Brand A, Van De Velde CJH, Melief CJM: Antibodies against p53 are associated with poor prognosis of colorectal cancer. Br J Cancer 1995;72:637-641.
16. Yonemura Y, Ninomiya I, Ohyama S, Kimura H, Yamaghuchi A, Fushida S, Kosaka T, Miwa K, Miyazaki I, Endou Y: Expression of c-erbB-2 oncoprotein in gastric carcinoma - Immuno-reactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma. Cancer 1991; 67:2914-2918.
17. 1 and prognosis in human breast cancer. Int J Cancer 1996;69:92-99.
18. 1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 1996;110:669-674.
19. 1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int J Cancer 1994;58:568-573.
20. 1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients. Cancer Res 1997;57:169-175.
21. 1 phase of the cell cycle. Cell 1991;65:701-713.
22. Xiong Y, Zhang H, Beach D: D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992;71:505-514.
23. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 1994;266:1821-1828.
24. Robbins BA, De La Vega D, Ogata K, Tan EM, Nakamura RM: Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pathol Lab Med 1987;11:841-845.
25. Maeda K, Chung YS, Onoda N, Kato Y, Arimoto Y, Nitta A, Yamada N, Kondo Y, Sowa M: Proliferating cell nuclear antigen (PCNA) labeling index of preoperative biopsy specimens in gastric carcinoma - with special reference to prognosis. Cancer 1994;73:528-533.
26. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Onoda N, Sawada T, Kato Y, Nitta A, Arimoto Y, Kondo Y, Sowa M: Tumor angiogenesis and tumor cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer 1995;72: 319-323.
27. Moertel CG: Accomplishment in surgical adjuvant therapy for large bowel cancer. Cancer 1992;70:1364-1371.